1-9 of 9
Christian Baumgartner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs

Karl J. Aichberger, Karoline V. Gleixner, Irina Mirkina, Sabine Cerny-Reiterer, Barbara Peter, Veronika Ferenc, Michael Kneidinger, Christian Baumgartner, Matthias Mayerhofer, Alexander Gruze, Winfried F. Pickl, Christian Sillaber, Peter Valent
Journal: Blood
Blood (2009) 114 (26): 5342–5351.
https://doi.org/10.1182/blood-2008-08-175190
Published: 2009
Journal Articles

Leukemic challenge unmasks a requirement for PI3Kδ in NK cell–mediated tumor surveillance

Eva Zebedin, Olivia Simma, Christian Schuster, Eva Maria Putz, Sabine Fajmann, Wolfgang Warsch, Eva Eckelhart, Dagmar Stoiber, Eva Weisz, Johannes A. Schmid, Winfried F. Pickl, Christian Baumgartner, Peter Valent, Roland P. Piekorz, Michael Freissmuth, Veronika Sexl
Journal: Blood
Blood (2008) 112 (12): 4655–4664.
https://doi.org/10.1182/blood-2008-02-139105
Published: 2008
Includes: Supplemental data
Journal Articles

Comorbidity as Prognostic Variable in MDS: Comparative Evaluation of the HCT-CI and CCI in a Core Data Set of 582 Patients of the Austrian MDS Platform.

Wolfgang R Sperr, Friedrich Wimazal, Michael Kundi, Christian Baumgartner, Thomas Noesslinger, Anabel Makrai, Reinhard Stauder, MD, Otto Krieger, Michael Pfeilstocker, MD, Peter Valent, MD
Journal: Blood
Blood (2008) 112 (11): 1648.
https://doi.org/10.1182/blood.V112.11.1648.1648
Published: 2008
Journal Articles

Effects of Bosutinib (SKI-606) in CML: Kinase Target Profile, Effects on BCR/ABL Mutants, and Synergism with Dasatinib in T315I+ Cells

Karoline Veronika Gleixner, MD, Lily L Remsing Rix, Christian Baumgartner, Uwe Rix, Alexander Gruze, Renata Anna Meyer, M.D., Winfried F. Pickl, MD, Christian Sillaber, Martin Augustin, Jeff Till, Giulio Superti-Furga, Peter Valent, MD
Journal: Blood
Blood (2008) 112 (11): 3195.
https://doi.org/10.1182/blood.V112.11.3195.3195
Published: 2008
Journal Articles

Phenotypic and Functional Characterization of CD34+/CD38-/CD123+ Leukemic Progenitor (Stem) Cells in AML: a Flow Cytometric Approach.

Harald Herrmann, MD, Christian Baumgartner, MD, Wolfgang R Sperr, MD, Steve Holmes, PhD, Peter Valent, MD
Journal: Blood
Blood (2008) 112 (11): 1340.
https://doi.org/10.1182/blood.V112.11.1340.1340
Published: 2008
Journal Articles

The effects of dasatinib on IgE receptor–dependent activation and histamine release in human basophils

Michael Kneidinger, Uwe Schmidt, Uwe Rix, Karoline V. Gleixner, Anja Vales, Christian Baumgartner, Christian Lupinek, Margit Weghofer, Keiryn L. Bennett, Harald Herrmann, Alexandra Schebesta, Wayne R. Thomas, Susanne Vrtala, Rudolf Valenta, Francis Y. Lee, Wilfried Ellmeier, Giulio Superti-Furga, Peter Valent
Journal: Blood
Blood (2008) 111 (6): 3097–3107.
https://doi.org/10.1182/blood-2007-08-104372
Published: 2008
Journal Articles

Dasatinib Inhibits the Growth of Neoplastic Human Eosinophils (EOL-1) through Targeting of FIP1L1-PDGFRα.

Christian Baumgartner, MD, Karoline V. Gleixner, M.D., Alexander Gruze, Puchit Samorapoompichit, M.D., Harald Esterbauer, M.D, Winfried F. Pickl, M.D, Christian Sillaber, M.D., Peter Valent, M.D.
Journal: Blood
Blood (2007) 110 (11): 3559.
https://doi.org/10.1182/blood.V110.11.3559.3559
Published: 2007
Journal Articles

The Plk-1 Inhibitor BI 2536 Counteracts the Growth of Neoplastic Mast Cells and Synergizes with the KIT D816V-Targeting Drug Midostaurin (PKC412) in Producing Growth-Inhibition.

Veronika Ferenc, MD, Karoline V. Gleixner, M.D., Alexander Gruze, M.D., Michael Kneidinger, M.D., Christian Baumgartner, M.D., Matthias Mayerhofer, M.D., Winfried F. Pickl, M.D., Christian Sillaber, M.D., Peter Valent, M.D.
Journal: Blood
Blood (2007) 110 (11): 3554.
https://doi.org/10.1182/blood.V110.11.3554.3554
Published: 2007
Journal Articles

The Plk-1 Inhibitor BI 2536 Counteracts Proliferation and Viability of CML Cells and Synergizes with Imatinib and Nilotinib (AMN107) in Producing Growth Inhibition.

Karoline V. Gleixner, MD, Veronika Ferenc, M.D., Alexander Gruze, Michael Kneidinger, M.D., Christian Baumgartner, M.D., Matthias Mayerhofer, M.D., Winfried F. Pickl, M.D., Christian Sillaber, M.D., Peter Valent, M.D.
Journal: Blood
Blood (2007) 110 (11): 1046.
https://doi.org/10.1182/blood.V110.11.1046.1046
Published: 2007